176 related articles for article (PubMed ID: 31954799)
1. Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases.
da Rocha Junior LF; Branco Pinto Duarte AL; de Melo Rêgo MJB; de Almeida AR; de Melo Vilar K; de Lima HD; Tavares Dantas A; de Ataíde Mariz H; da Rocha Pitta I; da Rocha Pitta MG
Immunol Lett; 2020 Apr; 220():38-43. PubMed ID: 31954799
[TBL] [Abstract][Full Text] [Related]
2. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
[TBL] [Abstract][Full Text] [Related]
3. Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis.
Liu Y; Shi J; Wang B; Zhou L; Zhou X; Du Y; Li D; Duan L; Hu Q; Chen W; Li P
Dis Markers; 2021; 2021():6331994. PubMed ID: 34136020
[TBL] [Abstract][Full Text] [Related]
4. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.
Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G
Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.
Cylwik B; Gruszewska E; Gindzienska-Sieskiewicz E; Kowal-Bielecka O; Chrostek L
Biochem Med (Zagreb); 2021 Jun; 31(2):020701. PubMed ID: 33927551
[TBL] [Abstract][Full Text] [Related]
6. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Newly Diagnosed Drug-Naive Patients with Systemic Autoimmune Diseases Revealed the Cleaved Peptide Tyrosine Tyrosine (PYY 3-36) as a Specific Plasma Biomarker of Rheumatoid Arthritis.
Balog JA; Kemeny A; Puskas LG; Burcsar S; Balog A; Szebeni GJ
Mediators Inflamm; 2021; 2021():5523582. PubMed ID: 34239365
[TBL] [Abstract][Full Text] [Related]
8. Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis.
Wallace DJ; Gavin IM; Karpenko O; Barkhordar F; Gillis BS
Rheumatol Int; 2015 Jun; 35(6):991-6. PubMed ID: 25377646
[TBL] [Abstract][Full Text] [Related]
9. Plasma interleukin-38 in patients with rheumatoid arthritis.
Xu WD; Su LC; He CS; Huang AF
Int Immunopharmacol; 2018 Dec; 65():1-7. PubMed ID: 30268016
[TBL] [Abstract][Full Text] [Related]
10. Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.
Yang X; Lin K; Ni S; Wang J; Tian Q; Chen H; Brown MA; Zheng K; Zhai W; Sun L; Jin S; Wang J
Arthritis Res Ther; 2017 Nov; 19(1):257. PubMed ID: 29166915
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of serum connective tissue growth factor in rheumatoid arthritis.
Ren J; Sun L; Sun X; Ma Z; Wang X; An Z; Zhao J
Clin Rheumatol; 2021 Jun; 40(6):2203-2209. PubMed ID: 33389316
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid level reflects the disturbances of glycosylation and acute-phase reaction in rheumatic diseases.
Chrostek L; Cylwik B; Gindzienska-Sieskiewicz E; Gruszewska E; Szmitkowski M; Sierakowski S
Rheumatol Int; 2014 Mar; 34(3):393-9. PubMed ID: 24346772
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease.
Gonzalez-Alvaro I; Ortiz AM; Garcia-Vicuña R; Balsa A; Pascual-Salcedo D; Laffon A
Clin Exp Rheumatol; 2003; 21(5):639-42. PubMed ID: 14611115
[TBL] [Abstract][Full Text] [Related]
14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in patients with rheumatoid arthritis.
Harada M; Mitsuyama K; Yoshida H; Sakisaka S; Taniguchi E; Kawaguchi T; Ariyoshi M; Saiki T; Sakamoto M; Nagata K; Sata M; Matsuo K; Tanikawa K
Scand J Rheumatol; 1998; 27(5):377-80. PubMed ID: 9808403
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate-deficient transferrin depends on disease activity in rheumatoid arthritis and systemic sclerosis.
Gruszewska E; Chludzinska A; Chrostek L; Cylwik B; Gindzienska-Sieskiewicz E; Szmitkowski M; Sierakowski S
Scand J Rheumatol; 2013; 42(3):203-6. PubMed ID: 23379548
[TBL] [Abstract][Full Text] [Related]
18. Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?
Dantas AT; Marques CD; da Rocha Junior LF; Cavalcanti MB; Gonçalves SM; Cardoso PR; Mariz Hde A; Rego MJ; Duarte AL; Pitta Ida R; Pitta MG
Dis Markers; 2015; 2015():519638. PubMed ID: 26078482
[TBL] [Abstract][Full Text] [Related]
19. Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus.
Wang H; Cao J; Lai X
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036035
[TBL] [Abstract][Full Text] [Related]
20. [Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis--relationship to clinical disease activity of RA].
Yoshinoya S; Mizoguchi Y; Hashimoto Y; Yamada A; Uchida S; Taniguchi A; Nishioka K; Miyamoto T
Ryumachi; 1991 Aug; 31(4):381-90. PubMed ID: 1948454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
